羊膜市场机会、成长动力、产业趋势分析与预测 2024 - 2032

2023 年，全球羊膜市场估值为 17 亿美元，预计 2024 年至 2032 年复合年增长率为 7.9%。发育中的胎儿提供重要的营养和生长因子。分娩后，这种膜由于其促进癒合的再生特性而在各种医疗和手术中发挥作用。对再生医学的日益关注预计将成为重要的成长动力。该领域旨在透过干细胞疗法、组织工程和生物材料等创新方法来恢復或替换受损的组织和器官。

羊膜在这些应用中的潜力正在获得认可，这主要是因为它们独特的特性。最近的研究强调了羊膜内关键生物活性分子的存在，增强了其在再生医学中的作用。从产品类型来看，市场可分为冻存羊膜和冻干羊膜。到 2032 年，冷冻保存领域预计将达到 17 亿美元，这主要是由于其在多个医学学科的广泛应用。

在眼科领域，冷冻羊膜用于治疗各种角膜缺陷，包括持续性上皮缺陷、溃疡和化学烧伤。该应用程式有助于加速癒合，同时最大限度地减少发炎和疤痕。 2023 年，眼科领域引领市场，营收达 3.421 亿美元。羊膜移植（AMT）在该领域用于治疗多种眼表疾病。

羊膜是胎盘的最内层，具有多种益处，例如透过其胶原蛋白成分支持上皮细胞生长、减少发炎、防止血管生成以及透过覆盖敏感的神经末梢提供镇痛作用。在美国，羊膜市场预计到 2032 年将达到 11 亿美元。随着技术的快速进步，对再生医学的日益重视预计将推动市场的进一步扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 再生医学需求不断成长
    • 慢性伤口的发生率上升
    • 生物技术与组织工程的进步
    • 提高羊膜产品的认知度与接受度
  • 产业陷阱与挑战
    • 羊膜产品保存期限有限
    • 严格的监理政策
• 成长潜力分析
• 监管环境
• 报销场景
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

• 主要趋势
• 冷冻保存
• 冻干的

第 6 章：市场估计与预测：按应用分类，2018 年 - 2032 年

• 主要趋势
• 手术伤口
• 眼科
• 干细胞生物学
• 再生医学
• 产前诊断
• 骨科
• 皮肤科
• 整型手术
• 牙科
• 妇科

第 7 章：市场估计与预测：依最终用途，2018 年 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心 (ASC)
• 专科诊所
• 研究和学术机构
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Amnio Technology, LLC
• Applied Biologics LLC
• BioTissue Holdings Inc.
• Celularity Inc.
• Corza Health, Inc.
• Integra LifeSciences Holdings Corporation
• MiMedx Group, Inc.
• Organogenesis Holdings Inc.
• Skye Biologics, Inc.
• Smith & Nephew plc

The Global Amniotic Membrane Market was valued at USD 1.7 billion in 2023 and is projected to experience a CAGR of 7.9% from 2024 to 2032. The amniotic membrane is a delicate, flexible tissue that lines the amniotic sac during pregnancy, serving as a protective barrier for the developing fetus while supplying vital nutrients and growth factors. Following childbirth, this membrane finds utility in various medical treatments and surgeries due to its regenerative properties that promote healing. The increasing focus on regenerative medicine is expected to be a significant growth driver. This field aims to restore or replace damaged tissues and organs through innovative methods such as stem cell therapy, tissue engineering, and biomaterials.

Amniotic membranes are gaining recognition for their potential in these applications, primarily because of their distinctive properties. Recent studies have highlighted the presence of key bioactive molecules within the amniotic membrane, reinforcing its role in regenerative medicine. In terms of product types, the market can be categorized into cryopreserved and lyophilized amniotic membranes. The cryopreserved segment is anticipated to reach USD 1.7 billion by 2032, primarily due to its extensive application across multiple medical disciplines.

In ophthalmology, cryopreserved amniotic membranes are used to treat various corneal defects, including persistent epithelial defects, ulcers, and chemical burns. This application aids in accelerating healing while minimizing inflammation and scarring. The ophthalmology segment led the market in 2023, with revenues reaching USD 342.1 million. Amniotic membrane transplantation (AMT) is utilized in this field to manage several ocular surface disorders.

The amniotic membrane, being the innermost layer of the placenta, provides various benefits, such as supporting epithelial cell growth through its collagen composition, reducing inflammation, preventing angiogenesis, and offering analgesic effects by covering sensitive nerve endings. In the United States, the amniotic membrane market is projected to reach USD 1.1 billion by 2032. This growth can be attributed to advanced healthcare facilities and key industry players. The rising emphasis on regenerative medicine, in line with rapid technological advancements, is expected to fuel further market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market segmentation
• 1.2 Market definition
• 1.3 Research design
• 1.4 Market size estimates and calculations
• 1.5 Key trends for market estimates
• 1.6 Forecast model
• 1.7 Primary research & validation
  • 1.7.1 Primary sources
  • 1.7.2 Data mining sources
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis, 2018 - 2032
• 2.2 Product trends
• 2.3 Application trends
• 2.4 End-use trends
• 2.5 Regional trends

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing demand for regenerative medicine
    • 3.2.1.2 Rising incidence of chronic wounds
    • 3.2.1.3 Advancements in biotechnology and tissue engineering
    • 3.2.1.4 Increasing awareness and acceptance of amniotic membrane products
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Limited shelf life of amniotic membrane products
    • 3.2.2.2 Stringent regulatory polices
• 3.3 Growth potential analysis
  • 3.3.1 By product
  • 3.3.2 By application
  • 3.3.3 By end-use
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technology landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Cryopreserved
• 5.3 Lyophilized

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Surgical wounds
• 6.3 Ophthalmology
• 6.4 Stem cell biology
• 6.5 Regenerative medicine
• 6.6 Prenatal diagnosis
• 6.7 Orthopedics
• 6.8 Dermatology
• 6.9 Plastic surgery
• 6.10 Dentistry
• 6.11 Gynecology

Chapter 7 Market Estimates and Forecast, By End Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers (ASCs)
• 7.4 Specialty clinics
• 7.5 Research and academic institutes
• 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Amnio Technology, LLC
• 9.2 Applied Biologics LLC
• 9.3 BioTissue Holdings Inc.
• 9.4 Celularity Inc.
• 9.5 Corza Health, Inc.
• 9.6 Integra LifeSciences Holdings Corporation
• 9.7 MiMedx Group, Inc.
• 9.8 Organogenesis Holdings Inc.
• 9.9 Skye Biologics, Inc.
• 9.10 Smith & Nephew plc